Skip to Content

Chifeng Pharmaceutical CO, China, 2023

GMP Audit Report

Company
Chifeng Pharmaceutical CO

Product(s)
Oxytetracycline Dihydrate

Country
China

Audit Year
2023

0.00 € 0.00 €
0.00 €